Table 2.
Baseline characteristics of CHARLS participants.
| Characteristic | Overall | Non-CMM | CMM | p-value |
|---|---|---|---|---|
| N = 11,221 | N = 10,787 | N = 434 | ||
| Age, Median (IQR), years | 58.0 (52.0, 65.0) | 58.0 (51.0, 65.0) | 62.0 (56.0, 69.0) | <0.001 |
| Gender, n (%) | 0.180 | |||
| Female | 5,916 (52.7%) | 5,673 (52.6%) | 243 (56.0%) | |
| Male | 5,305 (47.3%) | 5,114 (47.4%) | 191 (44.0%) | |
| Education level, n (%) | 0.555 | |||
| High school and above | 1,209 (10.8%) | 1,158 (10.7%) | 51 (11.8%) | |
| Less than high school | 10,012 (89.2%) | 9,629 (89.3%) | 383 (88.2%) | |
| Smoking status, n (%) | 4,455 (39.7%) | 4,286 (39.7%) | 169 (38.9%) | 0.779 |
| Drinking status, n (%) | 4,657(41.5%) | 4,490 (41.6%) | 167 (38.5%) | 0.210 |
| BMI, Median (IQR), kg/m2 | 23.2 (20.8, 25.9) | 23.1 (20.8, 25.8) | 25.5 (22.5, 28.0) | 0.201 |
| SBP, Median (IQR), mmHg | 127.3 (114.7, 142.0) | 127.0 (114.3, 141.7) | 137.0(122.3,153.0) | <0.001 |
| WBC, Median (IQR), ×109/L | 6.0 (5.0, 7.2) | 5.9 (4.9, 7.2) | 6.2 (5.1, 7.6) | 0.004 |
| FBG, Median (IQR), mg/dL | 102.6 (94.5, 113.9) | 102.1(94.3,112.5) | 137.2 (112.7, 167.0) | <0.001 |
| TG, Median (IQR), mg/dL | 106.2 (75.2, 156.6) | 105.3 (75.2, 154.0) | 144.7 (100.9, 232.8) | <0.001 |
| TC, Median (IQR), mg/dL | 190.2 (166.6, 215.7) | 190.2 (166.6, 215.3) | 196.6 (168.2, 223.5) | 0.006 |
| HDL-C, Median (IQR), mg/dL | 49.1 (40.2, 59.5) | 49.5 (40.2, 59.9) | 41.8 (34.0, 50.6) | <0.001 |
| LDL-C, Median (IQR), mg/dL | 114.0 (92.8, 137.2) | 114.0 (93.2, 137.2) | 114.8 (90.1, 139.2) | 0.368 |
| CR, Median (IQR), mg/dL | 0.8 (0.7, 0.9) | 0.8 (0.7, 0.9) | 0.8 (0.7, 0.9) | <0.001 |
| UA, Median (IQR), mg/dL | 4.3 (3.6, 5.2) | 4.3 (3.6, 5.2) | 4.6 (3.8, 5.5) | <0.001 |
| Hypertension, n (%) | 4,491 (40.0%) | 4,177 (38.7%) | 314 (72.4%) | <0.001 |
| Dyslipidemia, n (%) | 1,098 (9.8%) | 943 (8.7%) | 155 (35.7%) | <0.001 |
| Cancer, n (%) | 116 (1.0%) | 110 (1.0%) | 6 (1.4%) | 0.461 |
| Diabetes, n (%) | 1,958 (17.4%) | 1,566 (14.5%) | 392 (90.3%) | <0.001 |
| Heart disease, n (%) | 1,403 (12.5%) | 1,024(9.5%) | 379 (87.3%) | <0.001 |
| Stroke, n (%) | 267 (2.4%) | 147(1.4%) | 120 (27.6%) | <0.001 |
| Antidiabetic medication, n (%) | 464 (4.1%) | 313 (2.9%) | 151 (34.8%) | <0.001 |
| Antidyslipidemic medication, n (%) | 623 (5.6%) | 513 (4.8%) | 110 (25.3%) | <0.001 |
| CHG, Median (IQR) | 5.3 (5.0, 5.6) | 5.3 (5.0, 5.6) | 5.8 (5.4, 6.2) | <0.001 |
CMM, cardiometabolic multimorbidity; BMI, body mass index; SBP, systolic blood pressure; WBC, White blood cell; FBG, fasting blood glucose; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; CR, Creatinine; UA, uric acid.